ACRO Biomedical Co Ltd
Acro Biomedical Co., Ltd. engages in the development and marketing of nutritional products in Indiana and internationally. It is involved in the development and sale of cordyceps related products, a fungus used in traditional Chinese medicine. The company was formerly known as Killer Waves Hawaii, Inc. and changed its name to Acro Biomedical Co., Ltd. in January 2017. Acro Biomedical Co., Ltd. wa… Read more
ACRO Biomedical Co Ltd - Asset Resilience Ratio
ACRO Biomedical Co Ltd (ACBM) has an Asset Resilience Ratio of 0.00% as of June 2019. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2018–2018)
This chart shows how ACRO Biomedical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down ACRO Biomedical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $0.00 | 0% |
| Total Liquid Assets | $0.00 | 0.00% |
Asset Resilience Insights
- Limited Liquidity: ACRO Biomedical Co Ltd maintains only 0.00% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company maintains a balanced mix of cash and short-term investments.
ACRO Biomedical Co Ltd Industry Peers by Asset Resilience Ratio
Compare ACRO Biomedical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
464680
KQ:464680 |
Shell Companies | 97.32% |
|
Azure Holding Group Corp
PINK:AZRH |
Shell Companies | 0.00% |
|
Hana 30 Special Purpose Acquisition Company
KQ:469880 |
Shell Companies | 93.60% |
|
Cuspis Capital II Ltd
V:CCII-P |
Shell Companies | 97.65% |
|
0041B0
KQ:0041B0 |
Shell Companies | 77.82% |
|
Aloys Inc.
KQ:297570 |
Shell Companies | 1.22% |
|
Nh Special Purpose Acquisition 14 Co. Ltd
KQ:319400 |
Shell Companies | 1.35% |
Annual Asset Resilience Ratio for ACRO Biomedical Co Ltd (2018–2018)
The table below shows the annual Asset Resilience Ratio data for ACRO Biomedical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2018-12-31 | 0.00% | $0.00 | $1.48 Million | -- |